OncoTargets and Therapy
Volume 14, 2021 - Issue
Open access
44
Views
1
CrossRef citations to date
0
Altmetric
Short Report
Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV
Serena De Matteis1 Department of Specialistic, Diagnostic and Experimental Medicine, University of Bologna, Bologna, Italy
, Martina Ghetti2 Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola (FC), ItalyCorrespondence[email protected]
, Laura Gramantieri3 Center for Applied Biomedical Research, St. Orsola-Malpighi University Hospital, Bologna, Italy
, Giorgia Marisi2 Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola (FC), Italyhttps://orcid.org/0000-0003-4012-0042
& Andrea Casadei-Gardini4 Department of Medical Oncology, San Raffaele Scientific Institute IRCCS, Milan, Italyhttps://orcid.org/0000-0001-6289-7202
Pages 4305-4308
|
Published online: 30 Jul 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.